SEC Form 4 · accession 0001461959-18-000001
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S Rosenstadt
Officer — Chief Legal Officer · Director · 10% Owner
Period of report
Jan 5, 2018
Accepted (ET)
Mar 8, 2018 · 11:27 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionsF1 | $4.00 | Jun 5, 2017 | A | 12,500 | A | Mar 5, 2018 | Jun 5, 2022 | Common Stock | 12,500 | 887,500 | D |
| Incentive Stock OptionsF2 | $4.00 | Jun 5, 2017 | A | 25,000 | A | Mar 5, 2018 | Jun 5, 2022 | Common Stock | 25,000 | 912,500 | D |
Explanation of responses
- F1Issued for director services.
- F2Issued for officer services.